Sex Disparities of Genomic Determinants in Response to Immune Checkpoint Inhibitors in Melanoma.

Front Immunol · 2021 · PMC8594267 · PMID 34795662

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

26.4%) in patients who received anti-CTLA-4 agents; other associations did not reach statistical significance ( Figure S11A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.